The preDIlatation in tRanscathEter aortiC Valve implanTation Trial

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 170 participants.

Also called NCT02448927

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 170 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02448927
Other papers using this trial's data
  • Pre-Dilatation Versus No Pre-Dilatation for Implantation of a Self-Expanding Valve in All Comers Undergoing TAVR: The DIRECT Trial JACC. Cardiovascular interventions, 2019-04-22 DOI, PubMed 30928442

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Greece, Israel (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02448927. Randomized; triple masking; primary purpose treatment. Start 2015-05 (registry gives no type); primary completion 2018-05-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The preDIlatation in tRanscathEter aortiC Valve implanTation Trial
Acronym
DIRECT
Condition
Aortic Valve Stenosis
Intervention (Device)
balloon aortic valvuloplasty
Intervention (Device)
Transcatheter Aortic Valve Implantation
Lead sponsor
National and Kapodistrian University of Athens (class: other)

Record details

Record id
cardio:ct-nct02448927
Content hash
8851a0cdd63ceadc0803be33f0491089beab6eec143cd1a6fa5ac93e12be7730